Corrective and Preventive Action (CAPA) systems are a cornerstone of FDA-compliant quality management systems. When CAPA programs are weak or ineffective, FDA inspections frequently result in Form 483 observations or warning letters.
Our CAPA Management Services help organizations assess, remediate, and strengthen CAPA systems to ensure issues are effectively corrected, recurrence is prevented, and regulatory expectations are met.
FDA expects CAPA systems to drive meaningful improvement—not just document corrective actions. Ineffective CAPA programs often lead to:
Our approach aligns CAPA systems with FDA regulations, guidance, and inspectional focus areas.
We conduct comprehensive CAPA system assessments to evaluate how effectively your CAPA process identifies, manages, and resolves quality issues.
Assessment areas include:
Each assessment provides risk-based findings and clear remediation recommendations.
When CAPA systems fail to meet FDA expectations, we provide targeted CAPA remediation and system redesign support.
Remediation includes:
Our goal is to create CAPA systems that are effective, sustainable, and inspection-ready.
FDA expects organizations to verify that CAPAs actually work. We help design and implement robust CAPA effectiveness checks that demonstrate true issue resolution.
Effectiveness check support includes:
Strong CAPA systems rely on meaningful metrics. We help organizations develop CAPA metrics and trending programs that support decision-making and continuous improvement.
Metrics and trending include:
These insights support proactive risk management and demonstrate quality system control during FDA inspections.
We help organizations move beyond compliance to true quality system effectiveness
An effective CAPA system protects product quality, patient safety, and regulatory credibility. Let us help you build a CAPA program that meets FDA expectations and drives continuous improvement.
